Severe OSA was characterized by markedly elevated levels of inflammation-related biomarkers, including CRP, MII, CAR, and CLR, accompanied by significant reductions in MPV, albumin and PNI, indicating concurrent inflammatory activation and alterations in nutritional status with increasing disease severity. The gene discussed is ALB; the disease is obstructive sleep apnea syndrome.